PATENTLY ABSURD
AFTER all the laurels and accolades for developing a new-generation vaccine against COVID-19 at the height of the pandemic, the two competing companies that developed the mRNA jabs are facing off in a critical patent dispute. The outcome of the big-ticket litigation will determine how accessible the mRNA technology will be in developing future vaccines and therapies against a host of health hazards, ranging from influenza to cancer.
It took the industry by surprise when after a year of doing business peaceably and earning billions of dollars each, Moderna filed a patent infringement suit against its rival, PfizerBioNTech on August 26. BioNTech and Moderna had both developed their COVID-19 vaccines using the mRNA platform to attack the SARS-CoV-2 virus. While BioNTech, a biotechnology startup in Germany, tied up with multinational Pfizer for quick development of the Comirnaty vaccine, Moderna chose to go it alone to make its Spikevax vaccine.
Now, Moderna claims Pfizer-BioNTech has infringed three patents on its vaccine delivery system, which gets the drug inside a recipient's cells and generates a protein. In lawsuits filed in the US District Court for the District of Massachusetts and the Higher Regional Court of Düsseldorf, where BioNTech is based, Moderna says that Comirnaty infringes patents it had filed between 2010 and 2016 covering the company's "foundational mRNA technology". It accuses its competitor of copying "this groundbreaking technology" which was critical to the development of its own Spikevax.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
THE CIRCULARITY ARGUMENT
A circular economy can help India achieve its developmental aspirations while following the low-carbon pathway. It will also help address the challenges of waste management, pollution and overexploitation of natural resources. Industries are already innovating to reuse high-volume wastes and have shown that the transition can usher in both environmental and financial windfalls
Banking on flawed drug voluntary licences
The Medicines Patent Pool is pushing for more VLs, but its bad deal with Novartis on a cancer drug shows the pitfalls
Lasting solutions
For the first time, the UN has recognised the role of indigenous communities in tackling aridity. A repository of traditional knowledge India has the wherewithal to lead the way
IMD at 150
India's journey into modern weather forecasting took a decisive turn 150 years ago with the establishment of India Meteorological Department during the British rule. The agency has come a long way since then, shaping the way the country predicts and responds to its diverse climate challenges
Every drop counts
In drought-prone Marathwada region, 14 villages have managed to counter water shortage by budgeting the resource
Threat to survival
Hollongapar Gibbon Sanctuary in Assam faces ecological challenges as railway electrification and hydrocarbon exploration endanger its fragile biodiversity
'Migration is going to be a battlefield'
AMITAV GHOSH is one of the foremost chroniclers of our times. His literary sojourn includes writings on topics that range from languages to climate change to human lives. His latest book, Wild Fictions, brings some of his works on these issues under one title. In a conversation with RAJAT GHAI, Ghosh shares his views on the future of human movement. Excerpts:
Face of future
California wildfires confirm forest fires are intensifying in a hotter world, emitting substantial amounts of greenhouse gases and reinforcing global warming
Friends of the forest
Residents of 30 villages in Uttarakhand establish a model for public participation in saving forests from wildfires
Climate-crazy playbook
Just hours after his second (and final) term began on January 20, US President Donald Trump unleashed 46 presidential actions. Several of these are centred on the US' climate commitments, energy transition, migration and trade policies, and are likely to have negative global implications
